Alzheimer's disease

Lilly shares sizzle as investors await Alzheimer's data
Yahoo/Reuters
Fri, 06/12/15 - 09:33 am
Eli Lilly
Alzheimer's disease
solanezumab
Roche Takes Another Shot at Alzheimer’s After Biogen Success
Bloomberg
Tue, 06/9/15 - 10:20 am
Roche
Biogen
Alzheimer's disease
gantenerumab
The legal death of Actavis' Namenda strategy spells doom for the 'hard switch'
Fierce Pharma
Tue, 05/26/15 - 10:53 am
Actavis
Namenda
generics
hard switch
Alzheimer's disease
Upcoming Events: A Dosing Decision For BioMarin, Plus Roche To Get Alzheimer's Data
Seeking Alpha
Mon, 05/25/15 - 12:41 pm
Biomarin
Roche
Alzheimer's disease
RG1577
Actavis Must Keep its Older Alzheimer’s Pill on the Market
WSJ Pharmalot
Fri, 05/22/15 - 06:23 pm
Actavis
Alzheimer's disease
hard switch
Namenda XR
No Namenda hard switch? No problem, Actavis execs say, with Namzaric on the horizon
Fierce Pharma Marketing
Mon, 05/18/15 - 11:32 am
Actavis
Namenda
hard switch
Namenda XR
Namzaric
Alzheimer's disease
That Namenda hard switch Actavis wants? It could cost HHS $6B
Fierce Pharma Marketing
Tue, 05/12/15 - 08:10 am
Namenda XR
Alzheimer's disease
Actavis
HHS
hard switch
Actavis and its Forced Switch Could Cost Medicare $288M This Year: Study
WSJ Pharmalot
Thu, 05/7/15 - 11:06 am
Actavis
Namenda XR
Alzheimer's disease
Medicare
Biogen to Spend $2.5 Billion Before Alzheimer’s Drug Results
Bloomberg
Tue, 04/28/15 - 09:50 am
Biogen
Alzheimer's disease
BIIB037
Roche's $100M Alzheimer's study could shift the balance in R&D
Fierce Biotech
Mon, 04/27/15 - 09:16 pm
Roche
Alzheimer's disease
R&D
Biogen blueprints a big Phase III effort for its Alzheimer's hopeful
Fierce Biotech
Fri, 04/24/15 - 11:22 am
Biogen
Alzheimer's disease
aducanumab
Roche more confident in beating Alzheimer's after Biogen data
Yahoo/Reuters
Wed, 04/22/15 - 10:12 am
Roche
Alzheimer's disease
Biogen
gantenerumab
crenezumab
Actavis Wins a ‘Product Hopping’ Case as Namenda Battle Rages On
WSJ Pharmalot
Tue, 04/21/15 - 01:34 pm
Actavis
Namenda
Namenda XR
hard switch
Alzheimer's disease
Actavis: No apologies for seeking Alzheimer's drug profits
Yahoo/AP
Mon, 04/13/15 - 10:06 pm
Actavis
Alzheimer's disease
Namenda
Namenda XR
Alzheon CEO calls out Biogen, says his firm will be 1st to Alzheimer's finish line
BioPharma Dive
Fri, 04/10/15 - 03:48 pm
Alzheimer's disease
Alzheon
Biogen
Alzheon's CEO says he can beat Biogen with the world’s first Alzheimer’s drug
Bizjournals.com
Wed, 04/8/15 - 10:39 am
Alzheimer's disease
Alzheon
Biogen
Eisai Soars On Alzheimer’s Drug With Biogen: How Much Is BIIB037 Worth?
Barron's
Wed, 03/25/15 - 08:56 am
Eisai
Biogen Idec
Alzheimer's disease
BIIB037
New Alzheimer's Research Throws Cold Water on Biogen's Recent Breakthrough
Yahoo/Bloomberg
Tue, 03/24/15 - 08:47 am
Alzheimer's disease
Biogen Idec
BIIB037
Exclusive: Biogen shortens name, expands ambitions in Alzheimer's, ALS
Yahoo/Reuters
Mon, 03/23/15 - 09:13 am
Biogen Idec
ALS
Alzheimer's disease
Namenda antitrust suit heats up in NY court
BioPharma Dive
Fri, 03/20/15 - 11:04 am
Namenda
Actavis
Namenda XR
antitrust
Alzheimer's disease

Pages